SEC Form 4 · accession 0001437749-26-021315
GeoVax Labs, Inc. · GOVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Reynolds
Officer — CFO
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 4:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000832489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $1.18 | Jun 17, 2026 | A | 17,600 | A | — | Jun 17, 2036 | Common Stock | 17,600 | 17,600 | D |
Explanation of responses
- F1Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.